Article
Unraveling the Potential of ALK-Targeted Therapies in NSCLC: Comprehensive Insights and Future Directions
2024-01-08
Abstract excerpt
The current review comprehensively explores the multifaceted landscape of anaplastic lymphoma kinase (ALK) and its pivotal role, specifically within non-small cell lung cancer (NSCLC). It traces the trajectory of ALK's discovery, notably its fusion with nucleolar phosphoprotein (NPM)-1 in anaplastic large cell non-Hodgkin's lymphoma (ALCL) in 1994. It unfolds the subsequent impact of ALK gene alterations...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- fcdc8636-adcd-5e19-afab-108b941b4fd8
- DOI
- 10.20944/preprints202401.0541.v1
